A carregar...
厄洛替尼致间质性肺病4例并文献复习
Erlotinib is an agent of oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors which are used for non-small cell lung cancer. Although this class of agents is considered to be relatively safe, the most serious, but rare, adverse reaction is drug-associated interstitial lung disease...
Na minha lista:
| Publicado no: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
中国肺癌杂志编辑部
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5999954/ https://ncbi.nlm.nih.gov/pubmed/22901999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2012.08.08 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|